
Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma
Hematologic Oncology Update
00:00
Cell Anexor
The CR-8 may still be limited. You just, as you said, have to really accompany patients with supportive MOSU has nurses, more or two, in the patient for their weight, for their appetite and other drugs that will fight against this syndrome of waste. The question is, you know, you have a 30% response rate. Maybe if you give it with more supportive, more zero, you will have a little bit of increase of that.
Transcript
Play full episode